Brief: Organogenesis Holdings Posts Q2 EPS Of $0.15
Aug 9 (Reuters) - Organogenesis Holdings Inc ORGO.O :
* . REPORTS SECOND QUARTER AND FIRST HALF 2021 FINANCIAL
RESULTS
* Q2 EARNINGS PER SHARE $0.15
* SEES FY 2021 REVENUE $456 MILLION TO $472 MILLION
* Q2 REVENUE $123.2 MILLION VERSUS REFINITIV IBES ESTIMATE
OF
$107.6 MILLION
* Q2 EARNINGS PER SHARE ESTIMATE $0.07 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX2YhjmH
Further company coverage: ORGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers